These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8394239)

  • 21. Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.
    Dowson AJ; Massiou H; Laínez JM; Cabarrocas X
    Cephalalgia; 2002 Jul; 22(6):453-61. PubMed ID: 12133045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of acute migraine with subcutaneous sumatriptan.
    Cady RK; Wendt JK; Kirchner JR; Sargent JD; Rothrock JF; Skaggs H
    JAMA; 1991 Jun; 265(21):2831-5. PubMed ID: 1851894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial.
    Thomson AN; Arthur GP; Bergin PS; Pollock M; Parkin PJ; Flanagan M; Samson SA
    N Z Med J; 1993 May; 106(955):171-3. PubMed ID: 8389026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral sumatriptan in acute migraine.
    Goadsby PJ; Zagami AS; Donnan GA; Symington G; Anthony M; Bladin PF; Lance JW
    Lancet; 1991 Sep; 338(8770):782-3. PubMed ID: 1681162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sumatriptan in the treatment of acute migraine with aura.
    Banerjee M; Findley LJ
    Cephalalgia; 1992 Feb; 12(1):39-44. PubMed ID: 1313746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with oral sumatriptan: a placebo-controlled, dose-ranging study. Oral Sumatriptan Dose-defining Study Group.
    Patten JP
    J Neurol; 1991; 238 Suppl 1():S62-5. PubMed ID: 1646290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical profile of sumatriptan: efficacy in migraine.
    Pilgrim AJ
    Eur Neurol; 1994; 34 Suppl 2():26-34. PubMed ID: 7835380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
    Landy SH; Tepper SJ; Wein T; Schweizer E; Ramos E
    Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.
    Lampl C; Voelker M; Diener HC
    J Neurol; 2007 Jun; 254(6):705-12. PubMed ID: 17406776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine.
    Winner P; Cady RK; Ruoff GE; Frishberg BM; Alexander WJ; Zhang Y; Kori SH; Lener SE
    Mayo Clin Proc; 2007 Jan; 82(1):61-8. PubMed ID: 17285787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous sumatriptan in acute migraine.
    JAMA; 1991 Nov; 266(19):2703-4. PubMed ID: 1658406
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study.
    Carpay HA; Matthijsse P; Steinbuch M; Mulder PG
    Cephalalgia; 1997 Aug; 17(5):591-5. PubMed ID: 9251875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term efficacy of subcutaneous sumatriptan using a novel self-injector.
    Gross ML; Kay J; Turner AM; Jewsbury J; Cleal AL
    Headache; 1995; 35(10):601-6. PubMed ID: 8550361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A unique iontophoretic patch for optimal transdermal delivery of sumatriptan.
    Siegel SJ; O'Neill C; Dubé LM; Kaldeway P; Morris R; Jackson D; Sebree T
    Pharm Res; 2007 Oct; 24(10):1919-26. PubMed ID: 17577644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sumatriptan in the treatment of migraine.
    Ferrari MD
    Neurology; 1993 Jun; 43(6 Suppl 3):S43-7. PubMed ID: 8389011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of acute cluster headache with sumatriptan.
    Sumatriptan Cluster Headache Study Group
    N Engl J Med; 1991 Aug; 325(5):322-6. PubMed ID: 1647496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study Group.
    Dowson AJ; Ashford EA; Prendergast S; Hassani H; Roberts GW; Flöter T; Szczudlik A
    Int J Clin Pract Suppl; 1999 Aug; 105():25-33. PubMed ID: 10692719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety of sumatriptan in asthmatic migraineurs.
    Lloyd DK; Pilgrim AJ
    Cephalalgia; 1993 Jun; 13(3):201-4. PubMed ID: 8395345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.